Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CervoMed (CRVO) Cash from Investing Activities (2022 - 2025)

Historic Cash from Investing Activities for CervoMed (CRVO) over the last 6 years, with Q3 2025 value amounting to $7.6 million.

  • CervoMed's Cash from Investing Activities rose 19134.47% to $7.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.0 million, marking a year-over-year increase of 15802.33%. This contributed to the annual value of -$28.7 million for FY2024, which is N/A changed from last year.
  • CervoMed's Cash from Investing Activities amounted to $7.6 million in Q3 2025, which was up 19134.47% from -$254993.0 recorded in Q2 2025.
  • Over the past 5 years, CervoMed's Cash from Investing Activities peaked at $9.5 million during Q1 2023, and registered a low of -$40.6 million during Q2 2024.
  • Its 4-year average for Cash from Investing Activities is -$2.3 million, with a median of $3.0 million in 2022.
  • In the last 5 years, CervoMed's Cash from Investing Activities plummeted by 954427.88% in 2023 and then soared by 19134.47% in 2025.
  • CervoMed's Cash from Investing Activities (Quarter) stood at $7.0 million in 2022, then plummeted by 235.71% to -$9.5 million in 2023, then surged by 197.97% to $9.3 million in 2024, then dropped by 18.53% to $7.6 million in 2025.
  • Its last three reported values are $7.6 million in Q3 2025, -$254993.0 for Q2 2025, and $5.4 million during Q1 2025.